Comparison of the Ultrasonic Cardiac Output Monitor and Echocardiography for Hemodynamic Assessment in Pediatric Anesthesia

Comparison of the Ultrasonic Cardiac Output Monitor and Echocardiography for Hemodynamic Assessment in Pediatric Anesthesia: A Prospective Observational Study

This prospective observational pilot study evaluates agreement between Ultrasound Cardiac Output Monitor (USCOM) measurements and transthoracic echocardiography-derived hemodynamic parameters in pediatric patients under standardized general anesthesia prior to surgical incision. Under stable hemodynamic and ventilatory conditions, suprasternal Doppler-derived velocity time integral (VTI), stroke volume (SV), cardiac output (CO), stroke volume variation (SVV), and aortic valve area (AVA) are obtained sequentially with USCOM and echocardiography within a short time window without changes in ventilation, anesthetic depth, positioning, fluid therapy, or vasoactive support. Agreement is assessed using correlation and Bland-Altman analyses.

Study Overview

Detailed Description

This prospective observational pilot study is designed to evaluate the agreement between Ultrasound Cardiac Output Monitor (USCOM) measurements and transthoracic echocardiography-derived hemodynamic parameters in pediatric patients undergoing elective surgery under standardized general anesthesia.

After anesthesia induction and airway management, patients are allowed to reach stable hemodynamic and ventilatory conditions. Heart rate, noninvasive blood pressure, peripheral oxygen saturation, tidal volume, respiratory rate, and positive end-expiratory pressure are documented to confirm comparable physiological conditions during all measurements.

All measurements are performed before surgical incision and under unchanged ventilator settings, anesthetic depth, and patient positioning. No fluid administration, vasoactive medication, or ventilatory adjustments are made between techniques.

USCOM measurements are obtained first using a suprasternal approach to acquire spectral Doppler signals. Device-derived parameters, including velocity time integral (VTI), stroke volume (SV), cardiac output (CO), stroke volume variation (SVV), systemic vascular resistance (SVR), and device-calculated aortic valve area (AVA), are recorded consecutively during spontaneous or controlled mechanical ventilation without apnea. Only Doppler signals with clearly defined spectral envelopes are accepted. Measurements with artifacts or poor signal quality are repeated until optimal tracings are achieved.

Immediately afterward, transthoracic echocardiography is performed using a pediatric probe. Suprasternal Doppler recordings are aligned as parallel as possible to blood flow in the ascending aorta, and angle correction is applied when required. VTI is measured from the largest and most clearly defined spectral Doppler envelope. The aortic annulus diameter is obtained from the parasternal long-axis view during midsystole, and aortic valve area is calculated. Stroke volume is derived as aortic valve area × VTI, and cardiac output is calculated as stroke volume × heart rate. Inspiratory and expiratory VTI values are recorded to determine respiratory variation and calculate SVV.

USCOM and echocardiography measurements are performed sequentially within a 1-2-minute time window to minimize the impact of temporal hemodynamic variability. Each parameter is measured three consecutive times, and the average value is used for statistical analysis.

All examinations are conducted by a single experienced operator who completed supervised echocardiography training and independently performed at least 30 validated measurements before study initiation to minimize interobserver variability.

The primary objective is to assess agreement between USCOM and echocardiography for stroke volume and cardiac output measurements. Secondary objectives include correlation of suprasternal VTI values, agreement in SVV measurements, comparison of USCOM-calculated versus echocardiography-derived aortic valve area, and Bland-Altman analysis of all paired hemodynamic parameters.

Study Type

Observational

Enrollment (Actual)

57

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey (Türkiye)
        • Marmara University Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Pediatric patients aged 6 months to 15 years with ASA physical status I-II who are scheduled for elective surgery requiring general anesthesia. All participants undergo noninvasive suprasternal Doppler and transthoracic echocardiography measurements under standardized anesthetic conditions before surgical incision.

Description

Inclusion Criteria:

  • Pediatric patients aged 6 months to 15 years
  • ASA physical status I-II
  • Scheduled for elective surgery requiring general anesthesia
  • Written informed consent obtained from parent(s) or legal guardian(s)

Exclusion Criteria:

  • Intracardiac or extracardiac shunts
  • Aortic valve disease
  • Anatomical limitation preventing suprasternal Doppler assessment
  • Required Doppler angle correction >20° during echocardiography evaluation
  • Emergency surgery
  • Inability to obtain informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agreement Between USCOM and Echocardiography for Stroke Volume and Cardiac Output
Time Frame: Intraoperative, after induction and stabilization and before surgical incision (single assessment; within 1-2 minutes between methods).
Agreement of paired SV and CO values obtained by USCOM and echocardiography under stable conditions, evaluated using Bland-Altman analysis (bias and 95% limits of agreement) and correlation.
Intraoperative, after induction and stabilization and before surgical incision (single assessment; within 1-2 minutes between methods).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation Between USCOM VTI and Echocardiography VTI (Suprasternal Doppler)
Time Frame: Single intraoperative assessment after induction and stabilization and before surgical incision (measurements obtained sequentially within 1-2 minutes).
To evaluate the strength of association between velocity time integral (VTI) values obtained using suprasternal Doppler with USCOM and those measured by transthoracic echocardiography under stable anesthetic and ventilatory conditions.
Single intraoperative assessment after induction and stabilization and before surgical incision (measurements obtained sequentially within 1-2 minutes).
Agreement Between USCOM and Echocardiography for Stroke Volume Variation
Time Frame: Single intraoperative assessment after induction and stabilization and before surgical incision (measurements obtained sequentially within 1-2 minutes).
To assess agreement between USCOM-derived and echocardiography-derived stroke volume variation (SVV) values calculated from inspiratory and expiratory Doppler measurements using paired Bland-Altman analysis and correlation methods.
Single intraoperative assessment after induction and stabilization and before surgical incision (measurements obtained sequentially within 1-2 minutes).
Comparison of Device-Calculated Versus Echocardiography-Derived Aortic Valve Area
Time Frame: Single intraoperative assessment after induction and stabilization and before surgical incision (measurements obtained sequentially within 1-2 minutes).
To compare aortic valve area (AVA) values automatically calculated by USCOM using biometric algorithms with AVA values derived from echocardiographic aortic annulus measurement and Doppler velocity time integral.
Single intraoperative assessment after induction and stabilization and before surgical incision (measurements obtained sequentially within 1-2 minutes).
Bland-Altman Agreement of Paired Hemodynamic Variables
Time Frame: Single intraoperative assessment after induction and stabilization and before surgical incision (measurements obtained sequentially within 1-2 minutes).
To evaluate agreement between USCOM and echocardiography for paired hemodynamic variables, including stroke volume, cardiac output, velocity time integral, stroke volume variation, and aortic valve area, using Bland-Altman analysis with calculation of bias and limits of agreement.
Single intraoperative assessment after induction and stabilization and before surgical incision (measurements obtained sequentially within 1-2 minutes).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2021

Primary Completion (Actual)

March 1, 2022

Study Completion (Actual)

March 15, 2022

Study Registration Dates

First Submitted

January 6, 2026

First Submitted That Met QC Criteria

January 6, 2026

First Posted (Actual)

January 15, 2026

Study Record Updates

Last Update Posted (Actual)

January 15, 2026

Last Update Submitted That Met QC Criteria

January 6, 2026

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • USCOM-Echo

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Echocardiography

Clinical Trials on USCOM

Subscribe